MET Copy Number Gain Associates with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR Mutant Lung Cancer

被引：1
|
作者：
Yano, Seiji [1 ]
Nanjo, Shigeki [1 ]
Arai, Sachiko [1 ]
Takeuchi, Shinji [1 ]
Yamada, Tadaaki [1 ]
Okada, Yasunori [2 ]
Hata, Akito [3 ]
Katakami, Nobuyuki [3 ]
机构：
[1] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa, Japan
[2] Juntendo Univ, Tokyo, Japan
[3] Inst Biomed Res & Innovat, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
CNS Metastasis; osimertinib; MET copy number gain; EGFR-TKI resistance;
D O I：
10.1016/j.jtho.2016.11.269
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA08.03
引用
收藏
页码：S272 / S273
页数：2
相关论文
共 50 条
  • [1] MET Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR-mutant Lung Cancer
    Nanjo, Shigeki
    Arai, Sachiko
    Wang, Wei
    Takeuchi, Shinji
    Yamada, Tadaaki
    Hata, Akito
    Katakami, Nobuyuki
    Okada, Yasunori
    Yano, Seiji
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (03) : 506 - 515
  • [2] MET copy number gain is associated with gefitinib resistance in leptomeningeal carcinomatosis of EGFR-mutant lung cancer
    Nanjo, Shigeki
    Arai, Sachiko
    Wang, Wei
    Hata, Akito
    Katakami, Nobuyuki
    Yano, Seiji
    CLINICAL CANCER RESEARCH, 2018, 24 (17)
  • [3] Clonality of c-MET Copy Number Gain as a Determinant of Primary TKI Resistance in EGFR-Mutant NSCLC
    Lai, G.
    Nahar, R.
    Lim, T.
    Kwang, X.
    Liew, P.
    Lim, J.
    Aung, Z. W.
    Takano, A.
    Lim, W.
    Lau, D.
    Tan, W. L.
    Ang, M.
    Toh, C. K.
    Tan, B. S.
    Devanand, A.
    Too, C. W.
    Gogna, A.
    Ong, B. H.
    Koh, T.
    Kanesvaran, R.
    Ng, Q. S.
    Jain, A.
    Yuan, J.
    Lim, T.
    Lim, A.
    Hillmer, A.
    Zhai, W.
    Iyer, G.
    Tan, E. H.
    Tam, W.
    Tan, D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1769 - S1770
  • [4] EGFR mutation and striking response to gefitinib in a patient with leptomeningeal carcinomatosis and erlotinib-refractory adenocarcinoma lung cancer
    Choong, Nicholas W.
    Dietrich, Sascha
    Seiwert, Tanguy Y.
    Tretiakova, Maria S.
    Nallasura, Vidya
    Davies, Gareth C.
    Lipkowitz, Stanley
    Husain, Aliya N.
    Salgia, Ravi
    Ma, Patrick C.
    CANCER RESEARCH, 2006, 66 (08)
  • [5] Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer
    Petty, Russell D.
    Dahle-Smith, Asa
    Stevenson, David A. J.
    Osborne, Aileen
    Massie, Doreen
    Clark, Caroline
    Murray, Graeme I.
    Dutton, Susan J.
    Roberts, Corran
    Chong, Irene Y.
    Mansoor, Wasat
    Thompson, Joyce
    Harrison, Mark
    Chatterjee, Anirban
    Falk, Stephen J.
    Elyan, Sean
    Garcia-Alonso, Angel
    Fyfe, David Walter
    Wadsley, Jonathan
    Chau, Ian
    Ferry, David R.
    Miedzybrodzka, Zosia
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (20) : 2279 - +
  • [6] MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients
    Cappuzzo, F.
    Janne, P. A.
    Skokan, M.
    Finocchiaro, G.
    Rossi, E.
    Ligorio, C.
    Zucali, P. A.
    Terracciano, L.
    Toschi, L.
    Roncalli, M.
    Destro, A.
    Incarbone, M.
    Alloisio, M.
    Santoro, A.
    Varella-Garcia, M.
    ANNALS OF ONCOLOGY, 2009, 20 (02) : 298 - 304
  • [7] A Phase 2 Trial Assessing Osimertinib Activity Against Leptomeningeal Carcinomatosis in EGFR-Mutant Lung Cancer
    Akazawa, Y.
    Nanjo, S.
    Tamiya, M.
    Hata, A.
    Yamaguchi, T.
    Kumagai, T.
    Mori, M.
    Katakami, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S918 - S918
  • [8] Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer
    Fukuda, Koji
    Otani, Sakiko
    Takeuchi, Shinji
    Arai, Sachiko
    Nanjo, Shigeki
    Tanimoto, Azusa
    Nishiyama, Akihiro
    Naoki, Katsuhiko
    Yano, Seiji
    CANCER SCIENCE, 2021, 112 (09) : 3784 - 3795
  • [9] MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET
    Zhou, Jian-Ya
    Chen, Xi
    Zhao, Jing
    Bao, Zhang
    Chen, Xing
    Zhang, Pei
    Liu, Zhen-Feng
    Zhou, Jian-Ying
    CANCER LETTERS, 2014, 351 (02) : 265 - 271
  • [10] MET Copy-Number Status in Lung Adenocarcinomas with EGFR Alterations
    Barletta, J. A.
    Xiao, Y.
    Joshi, V. A.
    Jackman, D. M.
    Janne, P. A.
    Lee, C.
    Lindeman, N. I.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 664 - 664
12345